Pure Global

Roche Cobas HSV 1 and 2 assays - Taiwan Registration ddef3fa5dd6048a32a358adacba70cd4

Access comprehensive regulatory information for Roche Cobas HSV 1 and 2 assays in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ddef3fa5dd6048a32a358adacba70cd4 and manufactured by ROCHE MOLECULAR SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
ddef3fa5dd6048a32a358adacba70cd4
Registration Details
Taiwan FDA Registration: ddef3fa5dd6048a32a358adacba70cd4
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Roche Cobas HSV 1 and 2 assays
TW: ็พ…ๆฐๅฏ้œธๆ–ฏHSV 1ๅ’Œ2ๆชข้ฉ—่ฉฆๅŠ‘
Risk Class 2

Registration Details

ddef3fa5dd6048a32a358adacba70cd4

DHA05602735600

Company Information

United States

Product Details

The Roche Cobas HSV 1 and 2 assays performed on the cobas 4800 system are automated, qualitative in vitro diagnostic tests. This test uses real-time PCR to directly detect and type herpes simplex virus types 1 and 2 (HSV-I and HSV-2) DNA in samples of anogenital lesions taken by clinicians from symptomatic male and female patients. The purpose of the Roche Cabas HSV 1 and 2 tests is to assist in the diagnosis of anogenital HSV-1 and HSV-2 infections in symptomatic patients.

C Immunology and microbiology

C.3305 Seroanalysis of monoperiasis virus

import

Dates and Status

Jun 22, 2015

Jun 22, 2025